Literature DB >> 18829364

The metabolic syndrome, diabetes and lung dysfunction.

A Tiengo1, G P Fadini, A Avogaro.   

Abstract

Sleep-disordered breathing and sleep apnoea are conditions frequently associated with comorbidity, including obesity, diabetes, hypertension, insulin resistance (metabolic syndrome) and cardiovascular disease. The diabetic state (type 1 and type 2 diabetes) may be associated to diminished lung function and, in particular, decreased vital capacity, and the association between chronic obstructive pulmonary disease (COPD) and type 2 diabetes may be due to a shared inflammatory process. Also, the alteration in circulating endothelial progenitor cells found in respiratory disease, the metabolic syndrome and cardiovascular disease reflect a common condition of endothelial dysfunction.

Entities:  

Mesh:

Year:  2008        PMID: 18829364     DOI: 10.1016/j.diabet.2008.08.001

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  30 in total

1.  Comorbidity Distribution, Clinical Expression and Survival in COPD Patients with Different Body Mass Index.

Authors:  Miguel J Divo; Carlos Cabrera; Ciro Casanova; Jose M Marin; Victor M Pinto-Plata; Juan P de-Torres; Javier Zulueta; Jorge Zagaceta; Pablo Sanchez-Salcedo; Juan Berto; Claudia Cote; Bartolome R Celli
Journal:  Chronic Obstr Pulm Dis       Date:  2014-09-25

2.  The evaluation of Nesfatin-1 levels in patients with OSAS associated with metabolic syndrome.

Authors:  O Aksu; B Aydın; D K Doguç; I Ilhan; O Ozturk; A Altuntas; H Demirkan; B K Koroglu; M N Tamer
Journal:  J Endocrinol Invest       Date:  2014-11-29       Impact factor: 4.256

Review 3.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.

Authors:  Stanley M H Chan; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Pharmacol Ther       Date:  2019-02-26       Impact factor: 12.310

4.  Air Pollution and Lung Function Loss: The Importance of Metabolic Syndrome.

Authors:  L Zhang; G Crowley; S H Haider; M Zedan; S Kwon; A Nolan
Journal:  Austin J Pulm Respir Med       Date:  2016-06-17

5.  Metabolic syndrome biomarkers predict lung function impairment: a nested case-control study.

Authors:  Bushra Naveed; Michael D Weiden; Sophia Kwon; Edward J Gracely; Ashley L Comfort; Natalia Ferrier; Kusali J Kasturiarachchi; Hillel W Cohen; Thomas K Aldrich; William N Rom; Kerry Kelly; David J Prezant; Anna Nolan
Journal:  Am J Respir Crit Care Med       Date:  2011-11-17       Impact factor: 21.405

6.  Lysophosphatidic acid and apolipoprotein A1 predict increased risk of developing World Trade Center-lung injury: a nested case-control study.

Authors:  Jun Tsukiji; Soo Jung Cho; Ghislaine C Echevarria; Sophia Kwon; Phillip Joseph; Edward J Schenck; Bushra Naveed; David J Prezant; William N Rom; Ann Marie Schmidt; Michael D Weiden; Anna Nolan
Journal:  Biomarkers       Date:  2014-02-19       Impact factor: 2.658

7.  The relationship between physical activity, restless legs syndrome, and health-related quality of life in type 2 diabetes.

Authors:  Thiago Medeiros da Costa Daniele; Veralice Meireles Sales de Bruin; Adriana Costa e Forte; Débora Siqueira Nobre de Oliveira; Clara Mota Randal Pompeu; Pedro Felipe Carvalhedo de Bruin
Journal:  Endocrine       Date:  2012-12-01       Impact factor: 3.633

Review 8.  Particulate matter inhalation and the exacerbation of cardiopulmonary toxicity due to metabolic disease.

Authors:  Lisa Kobos; Jonathan Shannahan
Journal:  Exp Biol Med (Maywood)       Date:  2021-01-19

9.  Dynamic Metabolic Risk Profiling of World Trade Center Lung Disease: A Longitudinal Cohort Study.

Authors:  Sophia Kwon; Myeonggyun Lee; George Crowley; Theresa Schwartz; Rachel Zeig-Owens; David J Prezant; Mengling Liu; Anna Nolan
Journal:  Am J Respir Crit Care Med       Date:  2021-11-01       Impact factor: 21.405

10.  Reduced lung function is independently associated with increased risk of type 2 diabetes in Korean men.

Authors:  Chang-Hee Kwon; Eun-Jung Rhee; Jae-Uk Song; Jung-Tae Kim; Hyon Joo Kwag; Ki-Chul Sung
Journal:  Cardiovasc Diabetol       Date:  2012-04-24       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.